* Conducted across 16 sites in Brazil, the study included both a prospective cohort (583 patients) and a retrospective analysis (4,914 patients) to evaluate the effectiveness of troponin levels in diagnosing AMI risk.
* Results indicated that 74.4% of the prospective cohort qualified for a rule-out approach based on troponin levels, highlighting the potential for this method to improve patient evaluation in emergency settings.